|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan
|
Luke Timmerman |
01/03/12 |
Seattle
|
|
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles
|
Luke Timmerman |
12/23/11 |
Seattle
|
|
Allozyne Receives New Round
|
VentureDeal |
12/23/11 |
Seattle
|
|
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy
|
Luke Timmerman |
12/22/11 |
Seattle
|
|
Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO
|
Luke Timmerman |
12/14/11 |
San Diego
|
|
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs
|
Luke Timmerman |
12/12/11 |
Seattle
|
|
Groove Biopharma Receives $8,000,000 Series B Financing
|
VentureDeal |
12/12/11 |
Seattle
|
|
Allena Kicks Off With $15M, Security Firms Ink Funding, TeraDiode Takes In $10M, & More Boston-Area Deals News
|
Erin Kutz |
11/23/11 |
Boston
|
|
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News
|
Erin Kutz |
11/18/11 |
Boston
|
|
Agios Nabs $78M From Partner Celgene, Existing VCs, and Public Funds
|
Arlene Weintraub |
11/17/11 |
Boston
|
|
Agios Pharmaceuticals Obtains $78,000,000 Series C Round
|
VentureDeal |
11/17/11 |
Boston
|
|
Adesto Technologies Secures Series C Financing
|
VentureDeal |
10/26/11 |
San Francisco
|
|
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/13/11 |
Seattle
|
|
Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets
|
Luke Timmerman |
10/12/11 |
New York
|
|
Agios Pulls in $20M From Celgene, Under Extended Cancer Metabolism Partnership
|
Luke Timmerman |
10/05/11 |
Boston
|
|
Siluria Pockets $20M For Making Cleaner Plastics, Fuels
|
Luke Timmerman |
09/27/11 |
San Francisco
|
|
Siluria Technologies Lands $20,000,000 Series B Funding
|
VentureDeal |
09/27/11 |
San Francisco
|
|
Sprint, Amazon, BigDoor, Giant Thinkwell: The One-Minute Week in Seattle Tech Headlines
|
Curt Woodward |
09/13/11 |
Seattle
|
|
VentiRx Concentrates Its Bet on Cancer, and Seattle
|
Luke Timmerman |
09/13/11 |
Seattle
|
|
American Innovators Lose Big in Newly Passed Patent Bill
|
Robert Nelsen |
09/09/11 |
National
|
|
Theraclone Snaps Up $10.6M Financing
|
Luke Timmerman |
09/08/11 |
Seattle
|
|
Theraclone Sciences Secures $10,600,000 Series B Round
|
VentureDeal |
09/08/11 |
Seattle
|
|
Shocking Technologies Obtains $15,200,000 Series C Round
|
VentureDeal |
08/31/11 |
San Francisco
|
|
HubSpot Buys OneForty, Cambridge Diagnostics Startups Nab Funding, Hopper Closes $8M, & More Boston-Area Deals News
|
Erin Kutz |
08/24/11 |
Boston
|
|
Quanterix Finds $6M
|
Erin Kutz |
08/23/11 |
Boston
|
|
Pulmatrix Snags $14M, Embera Adds for $4.5 Addiction Drugs, Daktari Gets $1.2M, & More Boston-Area Life Sciences News
|
Erin Kutz |
08/19/11 |
Boston
|
|
Carbonite Goes Public At $10 a Share, PeerTransfer Pulls In $7.5M, BuyWithMe Picks Up Scoop St., & More Boston-Area Deals News
|
Erin Kutz |
08/17/11 |
Boston
|
|
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments
|
Arlene Weintraub |
08/15/11 |
Boston
|
|
Pulmatrix Secures $14,000,000 Series B Funding
|
VentureDeal |
08/15/11 |
Boston
|
|
DuPont Scoops Up “Silicon Ink” Maker Innovalight
|
Wade Roush |
07/25/11 |
San Francisco
|
|
Page 1 of
10 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.